These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19300249)

  • 41. Rodent models for HIV-associated neurocognitive disorders.
    Gorantla S; Poluektova L; Gendelman HE
    Trends Neurosci; 2012 Mar; 35(3):197-208. PubMed ID: 22305769
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Treatment of HIV infection from the neurologic viewpoint. Therapy must reach the brain].
    von Giesen HJ; Köller H; Arendt G
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():46-50. PubMed ID: 12043074
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment.
    Smit TK; Brew BJ; Tourtellotte W; Morgello S; Gelman BB; Saksena NK
    J Virol; 2004 Sep; 78(18):10133-48. PubMed ID: 15331746
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HIV dementia persists, but now it's a chronic disease.
    AIDS Alert; 2002 Apr; 17(4):46-8. PubMed ID: 12030200
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The electrophysiology of neuroHIV: A systematic review of EEG and MEG studies in people with HIV infection since the advent of highly-active antiretroviral therapy.
    Fernández-Cruz AL; Fellows LK
    Clin Neurophysiol; 2017 Jun; 128(6):965-976. PubMed ID: 28433855
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HIV and the brain.
    Highleyman L
    BETA; 2009; 21(4):16-29. PubMed ID: 20034243
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiretroviral treatment is associated with increased attentional load-dependent brain activation in HIV patients.
    Chang L; Yakupov R; Nakama H; Stokes B; Ernst T
    J Neuroimmune Pharmacol; 2008 Jun; 3(2):95-104. PubMed ID: 18247124
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HIV, antiretroviral therapies, and the brain.
    Liner KJ; Ro MJ; Robertson KR
    Curr HIV/AIDS Rep; 2010 May; 7(2):85-91. PubMed ID: 20425562
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CNS Neurotoxicity of Antiretrovirals.
    Lanman T; Letendre S; Ma Q; Bang A; Ellis R
    J Neuroimmune Pharmacol; 2021 Mar; 16(1):130-143. PubMed ID: 31823251
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Humanized mice: models for evaluating NeuroHIV and cure strategies.
    Honeycutt JB; Garcia JV
    J Neurovirol; 2018 Apr; 24(2):185-191. PubMed ID: 28831774
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Progress in clinical neurosciences: The neuropathogenesis of HIV infection: host-virus interaction and the impact of therapy.
    Power C; Gill MJ; Johnson RT
    Can J Neurol Sci; 2002 Feb; 29(1):19-32. PubMed ID: 11858531
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Macrophages and HIV-1.
    Cobos-Jiménez V; Booiman T; Hamann J; Kootstra NA
    Curr Opin HIV AIDS; 2011 Sep; 6(5):385-90. PubMed ID: 21734564
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia.
    Sevigny JJ; Albert SM; McDermott MP; McArthur JC; Sacktor N; Conant K; Schifitto G; Selnes OA; Stern Y; McClernon DR; Palumbo D; Kieburtz K; Riggs G; Cohen B; Epstein LG; Marder K
    Neurology; 2004 Dec; 63(11):2084-90. PubMed ID: 15596754
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer's disease?
    Fulop T; Witkowski JM; Larbi A; Khalil A; Herbein G; Frost EH
    J Neurovirol; 2019 Oct; 25(5):634-647. PubMed ID: 30868421
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Brain structural and functional recovery following initiation of combination antiretroviral therapy.
    Becker JT; Cuesta P; Fabrizio M; Sudre G; Vergis EN; Douaihy A; Bajo R; Schubert A; Lopez OL; Parkkonen L; Maestu F; Bagic A
    J Neurovirol; 2012 Oct; 18(5):423-7. PubMed ID: 22692914
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era.
    Kallianpur AR; Wang Q; Jia P; Hulgan T; Zhao Z; Letendre SL; Ellis RJ; Heaton RK; Franklin DR; Barnholtz-Sloan J; Collier AC; Marra CM; Clifford DB; Gelman BB; McArthur JC; Morgello S; Simpson DM; McCutchan JA; Grant I;
    J Infect Dis; 2016 Apr; 213(7):1065-73. PubMed ID: 26690344
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Failure to clear intra-monocyte HIV infection linked to persistent neuropsychological testing impairment after first-line combined antiretroviral therapy.
    Shiramizu B; Ananworanich J; Chalermchai T; Siangphoe U; Troelstrup D; Shikuma C; De Grutolla V; Sithinamsuwan P; Praihirunkit P; Rattanamanee S; Valcour V;
    J Neurovirol; 2012 Feb; 18(1):69-73. PubMed ID: 22207583
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications.
    Hong S; Banks WA
    Brain Behav Immun; 2015 Mar; 45():1-12. PubMed ID: 25449672
    [TBL] [Abstract][Full Text] [Related]  

  • 59. AIDS-associated mild neurocognitive impairment is delayed in the era of highly active antiretroviral therapy.
    Deutsch R; Ellis RJ; McCutchan JA; Marcotte TD; Letendre S; Grant I;
    AIDS; 2001 Sep; 15(14):1898-9. PubMed ID: 11579260
    [No Abstract]   [Full Text] [Related]  

  • 60. HIV-1/AIDS neuropathology in a Canadian teaching centre.
    Walsh K; Thompson W; Megyesi J; Wiley CA; Hammond R
    Can J Neurol Sci; 2004 May; 31(2):235-41. PubMed ID: 15198450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.